These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26773436)

  • 21. The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancers.
    Stangelberger A; Schally AV; Zarandi M; Heinrich E; Groot K; Havt A; Kanashiro CA; Varga JL; Halmos G
    Prostate; 2007 Sep; 67(12):1339-53. PubMed ID: 17624923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1/mac 25) is reduced in human prostate cancer and is inversely related to tumor volume and proliferation index in Lucap 23.12 xenografts.
    Tennant MK; Vessella RL; Sprenger CC; Sikes RA; Hwa V; Baker LD; Plymate SR
    Prostate; 2003 Jul; 56(2):115-22. PubMed ID: 12746836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xenografted small cell undifferentiated cancer of prostate: possible common origin with prostatic adenocarcinoma.
    van Haaften-Day C; Raghavan D; Russell P; Wills EJ; Gregory P; Tilley W; Horsfall DJ
    Prostate; 1987; 11(3):271-9. PubMed ID: 2825148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The identification of a novel antibody for CD133 using human antibody phage display.
    Glumac PM; Forster CL; Zhou H; Murugan P; Gupta S; LeBeau AM
    Prostate; 2018 Sep; 78(13):981-991. PubMed ID: 29790189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
    J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases.
    Lee S; Han JS; Chang A; Ross HM; Montironi R; Yorukoglu K; Lane Z; Epstein JI
    Hum Pathol; 2013 Mar; 44(3):427-31. PubMed ID: 23026197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM; Meeker AK; Epstein JI; Coffey DS
    Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient induction of pluripotent stem cells from granulosa cells by Oct4 and Sox2.
    Mao J; Zhang Q; Ye X; Liu K; Liu L
    Stem Cells Dev; 2014 Apr; 23(7):779-89. PubMed ID: 24083387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.
    Roudier MP; Winters BR; Coleman I; Lam HM; Zhang X; Coleman R; Chéry L; True LD; Higano CS; Montgomery B; Lange PH; Snyder LA; Srivastava S; Corey E; Vessella RL; Nelson PS; Üren A; Morrissey C
    Prostate; 2016 Jun; 76(9):810-22. PubMed ID: 26990456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
    Zhou W; Freed CR
    Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reprogramming of retinoblastoma cancer cells into cancer stem cells.
    Yue F; Hirashima K; Tomotsune D; Takizawa-Shirasawa S; Yokoyama T; Sasaki K
    Biochem Biophys Res Commun; 2017 Jan; 482(4):549-555. PubMed ID: 27856246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chick derived induced pluripotent stem cells by the poly-cistronic transposon with enhanced transcriptional activity.
    Katayama M; Hirayama T; Tani T; Nishimori K; Onuma M; Fukuda T
    J Cell Physiol; 2018 Feb; 233(2):990-1004. PubMed ID: 28387938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells.
    Li Q; Yin L; Jones LW; Chu GC; Wu JB; Huang JM; Li Q; You S; Kim J; Lu YT; Mrdenovic S; Wang R; Freeman MR; Garraway I; Lewis MS; Chung LW; Zhau HE
    Oncotarget; 2016 Dec; 7(51):84645-84657. PubMed ID: 27835867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LuCaP 35: a new model of prostate cancer progression to androgen independence.
    Corey E; Quinn JE; Buhler KR; Nelson PS; Macoska JA; True LD; Vessella RL
    Prostate; 2003 Jun; 55(4):239-46. PubMed ID: 12712403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostatic cell lineage markers: emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration.
    Liu AY; Corey E; Bladou F; Lange PH; Vessella RL
    Int J Cancer; 1996 Jan; 65(1):85-9. PubMed ID: 8543402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of American mink embryonic stem and induced pluripotent stem cell transcriptomes.
    Menzorov AG; Matveeva NM; Markakis MN; Fishman VS; Christensen K; Khabarova AA; Pristyazhnyuk IE; Kizilova EA; Cirera S; Anistoroaei R; Serov OL
    BMC Genomics; 2015; 16 Suppl 13(Suppl 13):S6. PubMed ID: 26694224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer.
    Timofeeva OA; Palechor-Ceron N; Li G; Yuan H; Krawczyk E; Zhong X; Liu G; Upadhyay G; Dakic A; Yu S; Fang S; Choudhury S; Zhang X; Ju A; Lee MS; Dan HC; Ji Y; Hou Y; Zheng YL; Albanese C; Rhim J; Schlegel R; Dritschilo A; Liu X
    Oncotarget; 2017 Apr; 8(14):22741-22758. PubMed ID: 28009986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
    Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
    Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FGFR1 and WT1 are markers of human prostate cancer progression.
    Devilard E; Bladou F; Ramuz O; Karsenty G; Dalès JP; Gravis G; Nguyen C; Bertucci F; Xerri L; Birnbaum D
    BMC Cancer; 2006 Nov; 6():272. PubMed ID: 17137506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.